» Articles » PMID: 16439441

Racial or Ethnic Differences in Allele Frequencies of Single-nucleotide Polymorphisms in the Methylenetetrahydrofolate Reductase Gene and Their Influence on Response to Methotrexate in Rheumatoid Arthritis

Overview
Journal Ann Rheum Dis
Specialty Rheumatology
Date 2006 Jan 28
PMID 16439441
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The anti-folate drug methotrexate (MTX) is commonly used to treat rheumatoid arthritis.

Objective: To determine the allele frequencies of five common coding single-nucleotide polymorphisms (SNPs) in the methylenetetrahydrofolate reductase (MTHFR) gene in African-Americans and Caucasians with rheumatoid arthritis and controls to assess whether there are differences in allele frequencies among these ethnic or racial groups and whether these SNPs differentially affect the efficacy or toxicity of MTX.

Methods: Allele frequencies in the 677, 1298 and 3 additional SNPs in the MTHFR coding region in 223 (193 Caucasians and 30 African-Americans) patients with rheumatoid arthritis who previously participated in one of two prospective clinical trials were characterised, and genotypes were correlated with the efficacy and toxicity of MTX. Another 308 subjects with rheumatoid arthritis who participated in observational studies, one group predominantly Caucasian and the other African-American, as well as 103 normal controls (53 African-Americans and 50 Caucasians) were used to characterise allele frequencies of these SNPs and their associated haplotypes.

Results: Significantly different allele frequencies were seen in three of the five SNPs and haplotype frequencies between Caucasians and African-Americans. Allele frequencies were similar between patients with rheumatoid arthritis and controls of the same racial or ethnic group. Frequencies of the rs4846051C, 677T and 1298C alleles were 0.33, 0.11 and 0.13, respectively, among African-Americans with rheumatoid arthritis. Among Caucasians with rheumatoid arthritis, these allele frequencies were 0.08 (p<0.001 compared with African-Americans with rheumatoid arthritis), 0.30 (p = 0.002) and 0.34 (p<0.001), respectively. There was no association between SNP alleles or haplotypes and response to MTX as measured by the mean change in the 28-joint Disease Activity Score from baseline values. In Caucasians, the 1298 A (major) allele was associated with a significant increase in MTX-related adverse events characteristic of a recessive genetic effect (odds ratio 15.86, 95% confidence interval 1.51 to 167.01; p = 0.021), confirming previous reports. There was an association between scores of MTX toxicity and the rs4846051 C allele, and haplotypes containing this allele, in African-Americans, but not in Caucasians.

Conclusions: : These results, although preliminary, highlight racial or ethnic differences in frequencies of common MTHFR SNPs. The MTHFR 1298 A and the rs4846051 C alleles were associated with MTX-related adverse events in Caucasians and African-Americans, respectively, but these findings should be replicated in larger studies. The rs4846051 SNP, which is far more common in African-Americans than in Caucasians, can also be proved to be a useful ancestry informative marker in future studies on genetic admixture.

Citing Articles

Practical Implementation of Artificial Intelligence-Based Deep Learning and Cloud Computing on the Application of Traditional Medicine and Western Medicine in the Diagnosis and Treatment of Rheumatoid Arthritis.

Wang S, Hou Y, Li X, Meng X, Zhang Y, Wang X Front Pharmacol. 2022; 12:765435.

PMID: 35002704 PMC: 8733656. DOI: 10.3389/fphar.2021.765435.


MTHFR Polymorphism Is Associated With Severe Methotrexate-Induced Toxicity in Osteosarcoma Treatment.

Zhang W, Liu Z, Yang Z, Feng C, Zhou X, Tu C Front Oncol. 2022; 11:781386.

PMID: 34976820 PMC: 8714641. DOI: 10.3389/fonc.2021.781386.


Impact of Posttranslational Modification in Pathogenesis of Rheumatoid Arthritis: Focusing on Citrullination, Carbamylation, and Acetylation.

Kwon E, Ju J Int J Mol Sci. 2021; 22(19).

PMID: 34638916 PMC: 8508717. DOI: 10.3390/ijms221910576.


An Ethnic Variation in the Acceptance of Biological Disease-Modifying Therapies: A University Hospital Experience.

Selvaskandan H, Moorthy A Cureus. 2021; 13(5):e15270.

PMID: 34194874 PMC: 8234561. DOI: 10.7759/cureus.15270.


Effects of Methylene Tetrahydro Folate Reductase Gene Polymorphisms on Methotrexate Toxicity in Egyptian Pediatric Acute Lymphocytic Leukaemia Patients.

Mostafa-Hedeab G, Elborai Y, Ebid G Iran J Pharm Res. 2021; 19(4):387-393.

PMID: 33841551 PMC: 8019867. DOI: 10.22037/ijpr.2020.1101296.


References
1.
Rayl E, Moroson B, Beardsley G . The human purH gene product, 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase. Cloning, sequencing, expression, purification, kinetic analysis, and domain mapping. J Biol Chem. 1996; 271(4):2225-33. DOI: 10.1074/jbc.271.4.2225. View

2.
Excoffier L, Slatkin M . Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol. 1995; 12(5):921-7. DOI: 10.1093/oxfordjournals.molbev.a040269. View

3.
Saag K, Kolluri S, Koehnke R, Georgou T, Rachow J, Hunninghake G . Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. Arthritis Rheum. 1996; 39(10):1711-9. DOI: 10.1002/art.1780391014. View

4.
Morabito L, Montesinos M, Schreibman D, Balter L, Thompson L, Resta R . Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides. J Clin Invest. 1998; 101(2):295-300. PMC: 508567. DOI: 10.1172/JCI1554. View

5.
van der Put N, Gabreels F, STEVENS E, Smeitink J, Trijbels F, Eskes T . A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am J Hum Genet. 1998; 62(5):1044-51. PMC: 1377082. DOI: 10.1086/301825. View